Moreover, our analysis suggested that the Asp541Glu polymorphism was associated with increased prostate cancer risk among Europeans and Africans but not among Asians in all genetic models, although Asp541Glu produced similar levels of RNASEL activity to those of the wildtype enzyme[15]. Here, RNASEL is linked to prostate carcinoma.